# Cureskin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cureskin

- Industry: Healthcare IT
- Headquarters: Bangalore, India
- Website: www.cureskin.com
- Total disclosed funding: $25M
- Latest round: Series B (Mar 13, 2024)
- Investors on record: 8

## About

Founded in 2017 and based in Karnataka, India, Cure And Care Wellness Private Limited, doing business as Cureskin, formerly known as Heallo Skin Expert App, operates as a dermatology platform that connects patients with skincare experts. The company was founded by its CEO, Gunavardhan Kakulapati, CTO, Ramakrishna R, and Charu Sharma. Cureskin raised venture funding from MGA Ventures. In March 2024, Cureskin raised USD 20 million in Series B funding led by HealthQuad, JSW Ventures, Khosla Ventures, and Sharrp Ventures.

Cureskin offers an artificial intelligence-enabled app for skin analysis. Users can take a photo of their skin, and the app will analyze it to detect and diagnose skin conditions such as acne, dark spots, scars, and pigmentation. The app also features a chat feature that recommends products, enables consultations with dermatologists in India, and helps create a personalized treatment plan.

The company plans to use the funds raised in March 2024 to expand its technology and products.

## Funding rounds

- Series B, Mar 13, 2024, $20M — Khosla Ventures, JSW Ventures, Sharrp Ventures, HealthQuad
- Series A, Mar 7, 2022, $5M — JSW Ventures, Sharrp Ventures, SenseAI Ventures
- Seed, Aug 1, 2017 — Y Combinator, Gagarin Capital, Heartbeat Labs

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Gagarin Capital (https://capitalatlas.ai/funds/gagarin-capital) — Seed
- Heartbeat Labs — Seed
- JSW Ventures (https://capitalatlas.ai/funds/jsw-ventures) — Series A, Series B
- Sharrp Ventures — Series A, Series B
- SenseAI Ventures (https://capitalatlas.ai/funds/senseai-ventures) — Series A
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series B
- HealthQuad (https://capitalatlas.ai/funds/healthquad) — Series B